Literature DB >> 11013354

Outcome of prophylactic radical lymphadenectomy with gastrectomy in patients with early gastric carcinoma without lymph node metastasis.

E Otsuji1, A Toma, S Kobayashi, K Okamoto, A Hagiwara, H Yamagishi.   

Abstract

BACKGROUND: Prophylactic extended lymphadenectomy with gastrectomy may prolong survival in patients with early gastric carcinoma without lymph node metastasis. However, the therapeutic value of extensive lymphadenectomy in patients with early gastric carcinoma remains controversial.
METHODS: The authors retrospectively analyzed 423 patients with early gastric carcinoma without lymph node metastasis who underwent gastrectomy and did not die of other diseases to evaluate the effect of prophylactic extended lymphadenectomy on postoperative survival. The postoperative survival rate of patients who underwent prophylactic extended lymphadenectomy was compared with that of patients who underwent prophylactic limited lymphadenectomy.
RESULTS: Although extended lymphadenectomy did not appear to improve the postoperative survival rate of patients with mucosal tumors, it did improve the postoperative survival rate of patients with submucosal tumors. Whether prophylactic extended lymphadenectomy was performed significantly affected outcome in patients with early gastric carcinoma who had submucosal tumors without regional lymph node metastasis.
CONCLUSIONS: Extensive lymphadenectomy with gastrectomy should be performed to prolong the survival of the patients with submucosal tumors.

Entities:  

Mesh:

Year:  2000        PMID: 11013354

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

Review 1.  Gastric adenocarcinoma: review and considerations for future directions.

Authors:  Bryan J Dicken; David L Bigam; Carol Cass; John R Mackey; Anil A Joy; Stewart M Hamilton
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

2.  R0 resection in the treatment of gastric cancer: room for improvement.

Authors:  Alberto Biondi; Roberto Persiani; Ferdinando Cananzi; Marco Zoccali; Vincenzo Vigorita; Andrea Tufo; Domenico D'Ugo
Journal:  World J Gastroenterol       Date:  2010-07-21       Impact factor: 5.742

3.  Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival.

Authors:  Norihiro Yuasa; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2004-04-30       Impact factor: 3.445

Review 4.  Chemotherapy for gastric cancer.

Authors:  Javier Sastre; Jose Angel Garcia-Saenz; Eduardo Diaz-Rubio
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

5.  Biologic predictors of survival in node-negative gastric cancer.

Authors:  David A Kooby; Arief Suriawinata; David S Klimstra; Murray F Brennan; Martin S Karpeh
Journal:  Ann Surg       Date:  2003-06       Impact factor: 12.969

6.  Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.

Authors:  Xiaoyuan Chu; Zhong-Fa Yang
Journal:  World J Surg Oncol       Date:  2015-06-01       Impact factor: 2.754

7.  CA19-9 serum levels predict micrometastases in patients with gastric cancer.

Authors:  Tomaz Jagric; Stojan Potrc; Katarina Mis; Mojca Plankl; Tomaz Mars
Journal:  Radiol Oncol       Date:  2016-04-23       Impact factor: 2.991

8.  Predictive risk factors associated with synchronous multiple early gastric cancer.

Authors:  Seok Hoo Jeong; Jungsuk An; Kwang An Kwon; Woon Kee Lee; Kyoung Oh Kim; Jun-Won Chung; Yoon Jae Kim; Dong Kyun Park; Jung Ho Kim
Journal:  Medicine (Baltimore)       Date:  2017-06       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.